Purpose: Exercise training has been shown to reduce combined cardiovascular mortality and hospitalizations in patients with chronic heart failure (CHF) with reduced ejection fraction (HFrEF). Whereas there are extensive data on exercise training for individuals with HFrEF in a research setting, the experience of delivering cardiac rehabilitation (CR) services in the clinical setting has not been well described. With little knowledge regarding the number of qualifying patients with HFrEF in the United States, we described our 18-month experience recruiting hospitalized inpatients and stable outpatients into phase 2 CR. Methods: Patients hospitalized with CHF HFrEF were tracked for enrollment in CR. Exercise training response was described for patients identifi ed as inpatients and for stable HFrEF outpatients referred from cardiology clinic or heart failure clinic. Results: The cohort included 83 patients hospitalized with CHF and 36 outpatients. Only 17% (14/83) of eligible HFrEF inpatients enrolled in CR following CHF hospitalization compared with 97% (35/36) outpatient referrals. Improvements in aerobic capacity for the total cohort were observed whether expressed as estimated metabolic equivalents (n = 19, 4.6 ± 1.6 to 6.2 ± 2.4, P < .0001) or V · O 2 peak (n = 14, 14.4 ± 3.5 to 16.4 ± 4.6 mL/kg/min, P = .02) for those who completed CR. Conclusion: Signifi cant barriers to recruiting and enrolling patients with HFrEF were observed and only 17% of inpatients attended CR. Systematic in-hospital referral with close followup in the outpatient setting has the potential to capture more eligible patients. The participation of referred stable outpatients with HFrEF was much higher. Regardless of the referral source, patients with HFrEF completing CR can expect improvements in aerobic capacity, muscle strength, and depressive symptoms.
xercise training has been shown to reduce combined cardiovascular mortality and hospitalizations in patients with chronic heart failure (CHF) with reduced ejection fraction (HFrEF). 1 , 2 As such, the Centers for Medicare & Medicaid Services (CMS) expanded cardiac rehabilitation (CR) coverage in February 2014 to include patients with a diagnosis of stable HFrEF taking evidence-based medications. Whereas there are extensive data on the safety and effi cacy of exercise training for individuals with HFrEF in a research setting, 1 , 3 , 4 the experience of delivering CR services in the United States in the clinical setting has not yet been described. Although patients with HFrEF benefi t from exercise programs, 2 , 5 they have unique and prominent comorbidity profi les compared with CR patients with coronary heart disease. 6 Thus, CR recruitment and programmatic protocols, including exercise training and heart failure (HF) counseling, must be tailored to suit the specifi c needs of this population. With little known regarding the number of qualifying HFrEF patients, we sought to describe our 18-month experience with recruiting hospitalized inpatients and stable outpatients with HFrEF in phase 2 CR. In addition, we describe the trajectory of patients with HFrEF who start phase 2 CR in terms of completion rates and exercise training responses.
METHODS

PATIENTS
The study sample included patients hospitalized with a diagnosis of HF with left ventricular ejection fraction (LVEF) of ≤ 35%. In addition, we followed up similar outpatients who were directly referred from outpatient cardiology or CHF clinics to phase 2 CR. The specifi c CMS description of eligibility for CR is as follows: benefi ciaries with stable, CHF defi ned as patients with LVEF of ≤ 35% and New York Heart Association class II to IV symptoms despite being on optimal HF therapy for at least 6 weeks. Stable patients are defi ned as patients who have not had a recent ( ≤ 6 weeks) or planned ( ≤ 6 months) major cardiovascular hospitalization or procedure (CMS Decision Memorandum for Coverage of CR Programs for CHF, February 18, 2014; https: www.cms.gov/medicare-coverage-database/details/ nca-decision-memo.aspx?NCAId = 270 ).
Data were prospectively collected for patients hospitalized with acute HF from June 2014 through December 2015. Eligible participants following an acute hospitalization were identifi ed via a weekly report generated through the electronic medical record (EMR). The report included patients with an LVEF ≤ 35% measured by echocardiogram, left heart catheterization, or nuclear imaging at any point in their medical history, were hospitalized with CHF, and resided within our phase 2 CR catchment area (Chittenden County, VT). Information obtained from the medical record included most recent LVEF measurement, HFrEF etiology (ischemic vs nonischemic), hospital discharge date, and time since original HFrEF diagnosis. In addition, outpatients who were directly referred from a cardiology or CHF clinics to CR were tracked. For these patients, clinical data were obtained through the EMR. All patients were stable as defi ned by the CMS decision memorandum for at least 6 weeks prior to enrolling in CR.
ATTENDANCE RATES
Participation in CR following hospitalization was defi ned by attendance of at least 1 CR session. Attendance rate at CR for hospitalized patients with HFrEF was calculated by dividing the number of patients attending at least 1 session by the total number of eligible patients identifi ed in the hospital. Exclusion criteria included a concurrent qualifying diagnosis to CR during that hospitalization (myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, heart valve surgery) or an improved LVEF > 35% on repeat echocardiogram prior to CR enrollment ( Figure ) . was defi ned as V · O 2 peak . Calibration was performed before each test as described previously. 9 Quality control was performed according to published guidelines. 10 Individuals performed the same exercise testing protocol at baseline and exit from CR. Patients who performed the baseline exercise tolerance tests with their private cardiologist (n = 12) did not have V · O 2 peak measured. Because expired gas analysis was not performed on all patients at baseline (39%), aerobic capacity in METs was estimated for all patients utilizing treadmill time (n = 42) or average walking speed during a 6-minute walk (n = 7).
CLINICAL DEMOGRAPHICS
11 Secondary outcomes analysis included 30 patients with expired gas analysis at baseline, 14 of whom repeated the measures following CR.
EXERCISE TRAINING PROTOCOL
The exercise training program generally consisted of 3 sessions per week of aerobic and strength training up to a total of 36 sessions. Patients were monitored during training sessions, and exercise intensity was adjusted to maintain participant heart rate (HR) in the range of 70% to 85% of the peak HR obtained on the entry exercise tolerance test and/or a Borg scale for rating of perceived exertion between "fairly light" and "hard" (11-15 on a scale of [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . 12 Typically, exercise training sessions comprised 25 minutes on the treadmill and 8 minutes on 3 other modalities including elliptical trainers; upright and seated steppers; and cycle, arm, and rowing ergometers. Resistance training included both upper and lower extremity exercises with most patients performing 1 set of 10 repetitions with a subjective rating of "hard." Patients were encouraged to exercise 1 to 2 times per week on their own to a total of 3 to 5 exercise sessions per week. To reduce the risk of hospitalizations and improve clinical outcomes, 1 , 13 , 14 HF counseling was provided on an individual basis with topics including symptoms; daily body weights, medication adherence, sodium and fl uid restrictions, aerobic and resistance exercise guidelines, food labels, and meal planning. Group CHF education sessions were also attended on a monthly basis.
STATISTICAL ANALYSIS
Baseline statistical analyses were performed with analysis of variance and χ 2 tests (SPSS Statistics, IBM, version 22, Armonk, NY). Paired t tests were used to compare outcomes data in patients who completed CR. Statistical significance was set at the level of P < .05. All data are reported as mean ± standard deviation.
RESULTS
CR ATTENDANCE RATE
The cohort included 124 patients hospitalized with a primary diagnosis of CHF with LVEF ≤ 35%. Of these patients, 34 qualifi ed for CR for another diagnosis during hospitalization and 7 had improved ejection fractions on repeat echocardiogram before enrolling in CR and were removed from the pool of patients. Subsequently, 83 potential CR participants were tracked for enrollment status. Prior to commencing CR, 41 patients were deemed inappropriate for CR by clinical staff due to signifi cant comorbidities as determined through review of the EMR or discussion with their cardiologist: hospice/palliative care (n = 27); severe mobility disability (n = 6); unstable CHF or other medical 
Ultimately 17% of patients with isolated HFrEF (14/83) enrolled in CR following an acute HF hospitalization despite our aggressive recruiting protocol ( Figure ) . Participants of CR were similar to those who did not attend in terms of LVEF, etiology of HFrEF (ischemic vs nonischemic), rate of new diagnosis, and time from original diagnosis (data not shown, P > .05). Signifi cant differences were observed by discharge status (home, subacute rehab, palliative care, or assisted living nursing care), with all 14 CR attendees discharged to home compared with 38 of 69 (55%) nonattendees ( P < .0001). In addition to the patients identifi ed through acute hospitalization, 36 patients with a primary diagnosis of HFrEF were referred directly from our outpatient cardiology or CHF clinics during the same period with 35 of 36 (97%) completing at least 1 session.
CLINICAL DEMOGRAPHICS
Baseline demographics were obtained for the 49 patients with HFrEF (19 female) who participated in phase 2 CR. No differences were noted between hospital and clinic-referred patients across all measures and thus baseline data were combined ( Table 1 ) . Twenty-seven patients completed CR, 13 discontinued for personal reasons (9 dropouts with no contact, 2 high copayments, 1 transportation limitations, and 1 moved out of state), 6 dropped out for medical reasons, and 3 were still attending the program at the time of this analysis. Mean number of CR sessions completed for the entire sample was 26 ± 14. No differences were observed between patients who completed or dropped out of CR across all baseline measures, including PHQ-9 (data not shown, P > .05), making it unlikely that baseline measures signifi cantly infl uenced program adherence.
CR TRAINING EFFECTS
Mean number of sessions for the 27 CR completers was 35 ± 1 with pre-and postmeasures obtained for 19 patients (4 refused exit evaluations, 3 had exercise-limiting orthopedic issues, and 1 individual received followup care out of state). Signifi cant improvements were observed in estimated METs, handgrip strength, MOS-SF-36, and PHQ-9 ( Table 2 ). For patients who completed CR, no differences were noted in baseline measures between those who performed exit measures and those who did not (data not shown, P > .05). Expired gas analysis was obtained in a subgroup of 14 patients pre-and post-CR with an increase in V · O 2 peak from 14.4 ± 3.5 mL/kg/min to 16.4 ± 4.6 mL/ kg/min ( P = .02, + 14%). In addition, 3 patients performed pre-and postprogram 6-minute walk tests with an average improvement of 81.4 ± 22.3 m ( P = .02, + 36%).
DISCUSSION
Only 17% of patients following an acute HF hospitalization attended phase 2 CR at our institution during the fi rst 18 months following the CMS coverage decision. Attendees of CR were more likely to be discharged to home rather than to subacute rehabilitative services or an assisted living nursing facility. In addition, 36 patients were directly referred to CR from our outpatient cardiology and CHF clinics accounting for an absolute CR enrollment 2.5 times greater than from the hospital setting. Ninety-seven percent of patients specifi cally referred to CR by their primary cardiologist as a therapeutic intervention subsequently enrolled. For most of these patients, the cardiologist walked the patient over to the CR area and registered the patient as a part of their comprehensive care. For all patients who completed CR, improvements in aerobic capacity and muscular strength were demonstrated, which is consistent with previous reports. 1 , 4 , 15 Our analysis indicates HFrEF patients are exceptionally diffi cult to recruit following hospitalization using current protocols, even with an automated list of admissions data provided to the CR program. This diffi culty is multifactorial. During a complex hospitalization for class IV HF symptoms, physicians may not yet consider the patient appropriate for CR and refrain from forcefully recommending participation. The strength of the physician recommendation is known to be a powerful predictor of CR participation. 16 In addition, without an automatic referral prompt or quality indicator within the discharge summary for HFrEF diagnoses, patients were not immediately identifi ed and contacted by a liaison while hospitalized, which is another signifi cant predictor of CR attendance. 17 Further complicating recruitment is the required 6-week period to optimize CHF medications prior to CR eligibility, making it diffi cult to schedule an early group visit at our CR program. Whereas some HFrEF patients following hospitalization display complex comorbidity profi les, oftentimes with more severe health and physical limitations, 6 others more rapidly return to their stable baseline and could safely commence CR without an arbitrarily imposed waiting period. For patients with coronary artery disease, delaying the start of CR results in a decreased likelihood of attendance at a rate of 1% for each 1-day increment in wait time. 18 Furthermore, Pack et al 19 showed that early appointments improved attendance to CR orientation sessions by 18% (10 days vs 35 days). Despite having a tracking system in place, CR staff found it challenging to determine the timeframe in which patients will be stable (6 weeks on optimal CHF medications without hospitalization), yet eligible to attend CR. Our cohort highlights this complex situation with 49% (41/83) of patient candidates eventually were determined to be inappropriate for CR. Finally, with 37% (31/83) of patients with HFrEF discharged to subacute rehabilitative services or assisted living nursing facilities, none of whom attended CR; it may be pertinent to consider alternative cardiovascular care delivery models for those unable to complete traditional programs. 20 Integrating cardiac care in skilled nursing facilities may also ease home transitions and potentially increase enrollment in CR programs. 21 Focusing recruitment on outpatient cardiology clinics seems to be a more promising and less time-intensive approach. Tracking progress of eligible patients through outpatient clinics enables a more clear determination of patient stability and appropriateness to attend a CR program. Furthermore, referrals are obtained and endorsed directly from a physician caring for the patient, an approach known to greatly increase CR attendance. 22 Our observations support this approach, as all but 1 patient (medically inappropriate due to diabetic foot ulcers) of 36 attended at least 1 CR session following a clinic-based referral. Unfortunately, we are unable to determine the denominator of patients with HFrEF seen in clinic and thus cannot calculate overall attendance rates from this referral source. CR programs not affi liated with outpatient cardiology or CHF clinics may be at a disadvantage in HFrEF recruitment and will need to develop innovative approaches through the offi ces of local cardiologists who are seeing these patients.
Our results support consistent results of multiple studies showing improvements in exercise capacity after completion of CR in patients with HFrEF.
1 Improvements were found in aerobic capacity whether calculated as estimated METs (35%, n = 19) or V · O 2 peak (14%, n = 14). In addition, both objective (handgrip strength) and subjective (MOS-SF-36) measures of muscle strength and physical function improved following CR exercise. Finally, modest reductions in depressive symptoms were also noted suggesting psychosocial benefi ts in this population consistent with other CR participants. 23 Limitations of our study include that the analysis was observational from a single clinical center. Our fi ndings, however, may be relevant for the methods of recruitment of patients with HFrEF in other clinical CR programs. With our catchment area including a mix of urban and rural areas, our attendance rates may differ compared with other regions. In addition, not all patients had aerobic capacity measured directly with expired gas analysis. Calculating METs based on treadmill time provides a reasonable proxy for aerobic capacity 11 and likely did not alter training results as confi rmed by subjects with V · O 2 peak analysis. Despite CMS approving CR for CHF in 2014, signifi cant barriers to recruiting and enrolling patients with HFrEF remain. Striving for systematic in-hospital referrals with close followup in the outpatient setting has the potential to capture a large number of eligible patients without excessive time spent reviewing medical records. We would suggest that the required 6-week waiting period is a hindrance to getting these individuals into CR as some patients stabilize quickly and thus could be evaluated by the medical director. As more information is obtained regarding the HFrEF population eligible for CR programs, recruitment strategies must continue to evolve. Regardless of the referral source, most patients with HFrEF completing CR programs can expect improvements in aerobic capacity, muscle strength, depressive symptoms, and clinical outcomes.
